In epithelial tumors, such as colorectal cancer, breast cancer and lung adenocarcinoma, several studies have demonstrated that OVOL2 suppress invasion capability by inhibiting EMT and OVOL2 protein expression level is related with patient’s prognosis45–47. The gene discussed is OVOL2; the disease is colorectal cancer.